Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FASCINATE: FeASibility of Cbct-guIded oNline Adaptive radioThErapy

NCT06691776 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT06691776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FASCINATE: FeASibility of Cbct-guIded oNline Adaptive radioThErapy
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
August 29, 2023
Completion date
December 1, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, cervical cancer, head and neck cancer, lung cancer, prostate cancer